Human parvovirus B19 antibodies are less frequent among patients treated with factor IX concentrate inactivated by ultrafiltration: A report from a single spanish institution [1]

Vox Sanguinis

Volumn 74, Issue 4, 1998, Pages 260-261

  Canales, Miguel A ^a,b   Pinilla, Javier ^a   Mateos, Pablo ^a   Zapico, Rosa Martinez ^b   Alvarez, Teresa ^a   Jiménez, Victor M ^a   Quintana, Manuel ^a   Villar, Ana ^a   Navarro, Fernando Hernández ^a   Magallón, Manuel ^a  

^a Department of Haematology   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 9 CONCENTRATE; VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGED; CHILD; HUMAN; LETTER; MAJOR CLINICAL STUDY; PARVOVIRUS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; ULTRAFILTRATION;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; COAGULATION PROTEIN DISORDERS; FACTOR IX; HUMANS; INFANT; MIDDLE AGED; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PREVALENCE; SPAIN; ULTRAFILTRATION;

EID: 0031927038     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030946     Document Type: Letter

References (10)

1. Bartolomei Corsi O, Azzi A, Morfini M, Fanci R, Rossi Ferrini P: Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentrates. J Med Virol 1988;25: 165-170.
2. Azzi A, Ciappi S, Zakvrzewska K, Morfini M, Mariani G, Mannucci PM: Human parvovirus B19 infection in hemophiliacs first infused with two high-purity, virally attenuated factor VIII concentrates. Am J Hematol 1992;39:228-230.
3. Rollag H, Patou G, Pattison JR, Degré M, Evensen SA, Fröland SS, Glomstein A: Prevalence of antibodies against parvovirus B19 in Norwegians with congenital coagulation factor defects treated with plasma products from small donor pools. Scand J Infect Dis 1991;23:675-679.
4. Peerlinck K, Goubau P, Reybrouck R, Desmyter J, Vermylen J: Parvovirus B19 antibodies in patients with haemophilia A. Thromb Haemost 1995;73:555-556.
5. Grosse-Bley A, Eis-Hübinger AM, Kaiser R, Oldenburg J, Brackmann HH, Schwarz TF, Scheneweis KE: Serological and virological markers of human parvovirus B19 infection in sera of hemophiliacs. Thromb Haemost 1994; 72:503-507.
6. Santagostino E, Mannucci PM, Gringeri A, Azzi A, Morfini M: Eliminating parvovirus B19 from blood products. Lancet 1994;343:798.
7. Ragni MV, Koch WC, Jordan JA: Parvovirus B19 infection in patients with hemophilia. Transfusion 1996;36:238-241.
8. Eis-Hübinger AM, Sasowski U, Brackmann HH, Kaiser R, Matz B, Schneweis KE: Parvovirus B19 DNA is frequently present in recombinant coagulation factor VIII products. Thromb Haemost 1996;76:1118.
9. Zimmerman TS: Purification of factor VIII by monoclonal antibody affinity chromatography. Semin Hematol 1991;25(suppl 1):25-26.
10. Hrinda ME, Huang C, Criss Tarr G, Weeks R, Feldman F, Schreiber AB: Preclinical studies of a monoclonal antibody-purified factor IX, Mononine™. Semin Hematol 1991;3(suppl 6): 6-14.